Prediction and prevention of delirium

Prediction and prevention of delirium - Prediction and prevention of delirium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000005591

Enrollment

168

Registered

2011-05-12

Start date

2011-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

delirium

Interventions

Ramelteon placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients newly admitted to emergency department

Exclusion criteria

Exclusion criteria: 1) Severe liver dysfunction 2) Patients given fluvoxamine 3) Alcohol dependence, amphetamine abuse

Design outcomes

Primary

Measure	Time frame
Rate of delirium	—

Secondary

Measure	Time frame
1. discontinuation due to adverse phenomenon 2. association between values of IL-1beta and NK activity and subsequent delirium	—

Countries

Japan

Contacts

Public ContactKotaro Hatta

Juntendo University Nerima Hospital Department of Psychiatry

khatta@juntendo.ac.jp03-5923-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026